Prurigo – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Prurigo – Drugs In Development, 2024 report and make more profitable business decisions.
Prurigo nodularis (PN) is a skin disease characterized by pruritic (itchy) nodules that usually appear on the arms or legs. It is a chronic disorder of the skin that is classically seen as multiple, firm, flesh to pink colored papules, plaques, and nodules commonly located on the extensor surfaces of the extremities. The exact cause of PN is unknown. The condition may be diagnosed based on observing signs such as extremely itchy skin with the formation of nodules. In some cases, a skin biopsy is used to confirm the diagnosis.
The Prurigo drugs in development market research report provide comprehensive information on the therapeutics under development for Prurigo, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Prurigo and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Prurigo | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 13 molecules, with 13 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Prurigo therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Prurigo pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Prurigo treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Beijing Puqi Pharmaceutical Technology Co LtdCelldex Therapeutics Inc
Galderma SA
Genentech USA Inc
Incyte Corp
JiangSu Qyuns Therapeutics Co Ltd
Kymera Therapeutics Inc
Luye Pharma Group Ltd
Maruho Co Ltd
Trevi Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Prurigo reports